Company: SVV
Filing Date: 2025-05-13
Form Type: S-3
Source: 0001193125-25-118371
Chunk: 9

Company: Savers Value Village, Inc.
Filing Date: 2025-05-13
Form: S-3
Chunk 9
---
Where You Can Find More Information.”

Our principal executive office is located at 11400 S.E. 6th Street, Suite 125, Bellevue, WA 98004.

7

RISK FACTORS

Investing in our common stock involves risk. You should carefully consider the specific risks discussed or incorporated by reference in this
prospectus and any applicable prospectus supplement, together with all the other information contained in any applicable prospectus supplement and/or in any free writing prospectuses we have authorized for use in connection with a specific offering,
and under similar headings in the documents that are incorporated by reference in this prospectus and the applicable prospectus supplement. You should also consider the risks, uncertainties and assumptions discussed under the caption “Risk
Factors” included in our 2024 Annual Report, which is incorporated by reference into this prospectus, and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. The occurrence of
any of these risks might cause you to lose all or part of your investment in the offered securities. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have material adverse effects on
our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business,
financial condition, results or operations or cash flow could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment.

8

USE OF PROCEEDS

We will not receive any proceeds from the sale of our common stock by the selling stockholders. The Registration Rights Agreement (as defined
below) sets forth our obligation to reimburse certain expenses that are incurred by the Ares Funds (as defined below) that are selling stockholders. The selling stockholders will pay any underwriting discounts, selling commissions and stock transfer
taxes applicable to the sale of the shares of common stock. We will pay all other costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including, without limitation, all registration and filing
fees, the listing fees of the NYSE and fees and expenses of our counsel, counsel for the selling stockholders and our independent registered public accountants.

9

SELLING STOCKHOLDERS The following table sets forth the beneficial ownership of our common stock as